Optimizing Pharmaceutical Isolator Design

Publisher: Germfree Laboratories Inc

Access this content

Your content has been opened.

Please verify you are a human before downloading this content.

Optimizing Pharmaceutical Isolator Design has been emailed to . Entered the wrong email?

Don't see the content in your inbox?
Make sure to check your spam and other messages folders.

Can't get to your email right now?

To complete your registration and access this content, enter the sign-in code sent to your email.

Please enter a valid verification code.

Code sent to:

Also, remember to check in your spam, promotions, and other folders.

Your Email

Your Full Name

Your Company

Your Job Function

Register to access Pharmaceutical Manufacturing Resource Directory content

Your work email

Register to access this content

Your Work Email

Your Full Name

Your Company

Your Job Function

By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.

Optimizing Pharmaceutical Isolator Design

The isolator industry is pivotal to providing crucial solutions for safeguarding equipment and processes across a variety of sectors. Isolators ensure optimal performance and integrity, from laboratory experiments to industrial processes.

Similar content you might be interested in

TABLET COATING: OPTIMAL UNIFORMITY AND FLEXIBILITY

Publisher: L.B. Bohle USA

Tablets are the most important oral dosage form in the pharmaceutical industry. The advantages of tablets are numerous. First and foremost is the ability to precisely control dosage and the high stability of active ingredients. In addition, tablets can be produced quickly and in large quantities and offer flexible design freedom in terms of size, shape, and color. Tablets can be effervescent, dissolving, or dispersible, dissolving tablets, lozenges, or enteric-coated and retarding tablets, as well as uncoated and coated tablets.

Download Content »

Cocrystals: A Regulatory Rebirth

Publisher: Triclinic Labs, Inc

What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues? The FDA reclassification of cocrystals as active pharmaceutical ingredients (APIs) has created exciting opportunities for the pharmaceutical industry. That reclassification means cocrystals can now be developed as if they were polymorphs, providing new avenues for dealing with poor API physical properties and extending intellectual property lifetimes. It is important to understand how the revised guideline impacts API development, regulatory submissions, and intellectual property protection. Those topics are discussed in this whitepaper. Also considered is the importance of identifying whether an API is a salt or a cocrystal, a critical classification from a regulatory point of view. In addition, a list of FDA-approved, marketed cocrystals is presented. Finally, recommendations for cocrystal screening, evaluation, formulation, and production at scale are given.

Download Content »

797-Revisions Impacting Pharmacy Purchasing & Products

Publisher: Advanced Cleanroom Microclean (ACM)

Discover the latest on cleanroom standards with the Upcoming 797 Revisions PDF by Eric Kastango, featured in PPP magazine. Advanced Cleanroom Microclean is committed to keeping you informed about critical updates in GMP cleaning and certification. Our expert-led training sessions and advanced cleanroom services ensure compliance and safety for your facilities. Visit our news page to stay updated on industry advancements and company updates.

Download Content »